EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Consensus Report on the Use of Continuous Glucose Monitoring in Chronic Kidney Disease and Diabetes

Connie M Rhee iD, Roma Y Gianchandani iD, David Kerr iD, Athena Philis-Tsimikas, Csaba P Kovesdy iD, Robert C Stanton iD, Andjela T Drincic iD, Rodolfo J Galindo iD, Kamyar Kalantar-Zadeh, Joshua J Neumiller iD, Ian H de Boer, Marcus Lind iD und 6 weitere

Journal of Diabetes Science and Technology · 2025-01 · 19 (1) · 217-245

DOI: 10.1177/19322968241292041 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Diabetes Science and Technology, online erschienen am 29.11.2024. Verfasst von Connie M Rhee und 17 weiteren Autor:innen. Beteiligte Einrichtung: VA Greater Los Angeles Healthcare System, UCLA David Geffen School of Medicine, Los Angeles, CA, USA. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Blood Glucose Self-Monitoring, Blood Glucose. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 166 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIH HHS, Abbott Diabetes Care.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This report represents the conclusions of 15 experts in nephrology and endocrinology, based on their knowledge of key studies and evidence in the field, on the role of continuous glucose monitors (CGMs) in patients with diabetes and chronic kidney disease (CKD), including those receiving dialysis. The experts discussed issues related to CGM accuracy, indications, education, clinical outcomes, quality of life, research gaps, and barriers to dissemination. Three main goals of management for patients with CKD and diabetes were identified: (1) greater use of CGMs for better glycemic monitoring and management, (2) further research evaluating the accuracy, feasibility, outcomes, and potential value of CGMs in patients with end-stage kidney disease (ESKD) on hemodialysis, and (3) equitable access to CGM technology for patients with CKD. The experts also developed 15 conclusions regarding the use of CGMs in this population related to CGMs’ unique delivery of both real-time information that can guide monitoring and management of glycemia and continuous and predictive data in this population, which is at higher risk for hypoglycemia and hyperglycemia. The group noted three major clinical gaps: (1) CGMs are not routinely prescribed for patients with diabetes and CKD; (2) CGMs are not approved by the United States Food and Drug Administration (FDA) for patients with diabetes who are on dialysis; and (3) CGMs are not routinely available to all of those who need them because of structural barriers in the health care system. These gaps can be improved with greater stakeholder collaboration, education, and awareness brought to the use of CGM technology in CKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicBlood Glucose Self-MonitoringBlood GlucoseHumansDiabetes MellitusRenal DialysisContinuous Glucose Monitoring

Stichwörter der Autor:innen

chronic kidney diseasecontinuous glucose monitordiabetesdiabetic kidney diseasedialysisend-stage kidney disease

Substanzen

Blood Glucose

Autor:innen und Institutionen

  • VA Greater Los Angeles Healthcare System, UCLA David Geffen School of Medicine, Los Angeles, CA, USA.
  • Cedars-Sinai Health Systems, Los Angeles, CA, USA.
  • Center for Health Systems Research, Sutter Health, Santa Barbara, CA, USA.
  • Scripps Whittier Diabetes Institute, San Diego, CA, USA.
  • The University of Tennessee Health Science Center, Memphis, TN, USA.
  • Joslin Diabetes Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

ORCID-Profile: Connie M Rhee, Roma Y Gianchandani, David Kerr, Csaba P Kovesdy, Robert C Stanton, Andjela T Drincic, Rodolfo J Galindo, Joshua J Neumiller, Marcus Lind, Alessandra T Ayers, Cindy N Ho, Rachel E Aaron, Tiffany Tian, David C Klonoff

Förderung

  • NIDDK NIH HHS
  • NIH HHS
  • Abbott Diabetes Care
  • Dexcom

Zitieren

APA

Rhee, C. M., Gianchandani, R. Y., Kerr, D., Philis-Tsimikas, A., Kovesdy, C. P., Stanton, R. C., Drincic, A. T., Galindo, R. J., Kalantar-Zadeh, K., Neumiller, J. J., de Boer, I. H., Lind, M., Kim, S. H., Ayers, A. T., Ho, C. N., Aaron, R. E., Tian, T., & Klonoff, D. C. (2025). Consensus Report on the Use of Continuous Glucose Monitoring in Chronic Kidney Disease and Diabetes. Journal of Diabetes Science and Technology, 19(1), 217-245. https://doi.org/10.1177/19322968241292041

Vancouver

Rhee CM, Gianchandani RY, Kerr D, Philis-Tsimikas A, Kovesdy CP, Stanton RC, et al. Consensus Report on the Use of Continuous Glucose Monitoring in Chronic Kidney Disease and Diabetes. Journal of Diabetes Science and Technology. 2025;19(1):217-245. doi:10.1177/19322968241292041

BibTeX
@article{Rhee2025,
  author = {Rhee, Connie M and Gianchandani, Roma Y and Kerr, David and Philis-Tsimikas, Athena and Kovesdy, Csaba P and Stanton, Robert C and Drincic, Andjela T and Galindo, Rodolfo J and Kalantar-Zadeh, Kamyar and Neumiller, Joshua J and de Boer, Ian H and Lind, Marcus and Kim, Sun H and Ayers, Alessandra T and Ho, Cindy N and Aaron, Rachel E and Tian, Tiffany and Klonoff, David C},
  title = {Consensus Report on the Use of Continuous Glucose Monitoring in Chronic Kidney Disease and Diabetes},
  journal = {Journal of Diabetes Science and Technology},
  year = {2025},
  volume = {19},
  number = {1},
  pages = {217--245},
  doi = {10.1177/19322968241292041}
}
Kostenlos starten →